Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

INDUCE: A Prospective 2-Year Spine Registry

NCT: NCT06971835 · ENROLLING_BY_INVITATION

NCT IDNCT06971835
StatusENROLLING_BY_INVITATION
Start Date2026-02-17
SponsorRed Rock Regeneration Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used to promote fusion in the cervical or lumbar spine. The secondary objective is to assess patient reported outcomes following the use of NMP in the treatment of the spine.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑